World's Best Scientists 2026 revealed!
Award Badge
Molecular Biology
Italy
2026
Award Badge
Genetics and Molecular Biology
Italy
2024

D-Index & Metrics

Molecular Biology

D-Index
131
Citations
78692
World Ranking
181
National Ranking
3

Medicine

D-Index
133
Citations
79534
World Ranking
2199
National Ranking
45

Luigi Naldini publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Luigi Naldini sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 501 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Luigi Naldini D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Luigi Naldini sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 131 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Molecular Biology in Italy Leader Award
  • 2025 - Research.com Molecular Biology in Italy Leader Award
  • 2024 - Research.com Genetics and Molecular Biology in Italy Leader Award
  • 2023 - Research.com Genetics and Molecular Biology in Italy Leader Award
  • 2023 - Research.com Molecular Biology in Italy Leader Award
  • 2022 - Research.com Genetics and Molecular Biology in Italy Leader Award
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)

Overview

Luigi Naldini is affiliated with Vita-Salute San Raffaele University in Italy. Their research spans multiple fields within biochemistry, genetics, molecular biology, and medicine, with a significant focus on molecular biology, genetics, immunology, oncology, and physiology. The scientist has contributed extensively to virus-based gene therapy, CRISPR and genetic engineering, CAR-T cell therapy, immune cells in cancer, extracellular vesicles in disease, glioma diagnosis and treatment, and pluripotent stem cells research.

Naldini's most frequently published work appears in journals such as Blood, Molecular Therapy, Science Translational Medicine, Neuro-Oncology, and HemaSphere, with multiple publications across these venues.

Recent papers authored by Naldini or involving collaborations include:

  • ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update, 2021, Stem Cell Reports
  • Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access, 2022, The Lancet
  • IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer, 2023, Nature
  • Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking, 2020, Nature Biotechnology
  • Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress, 2022, Nature Immunology

Frequent co-authors collaborating with Naldini include Bernhard Gentner, Fabio Ciceri, Alessandro Aiuti, Ivan Merelli, and Samuele Ferrari.

Their research topics incorporate:

  • Virus-based gene therapy research
  • CRISPR and Genetic Engineering
  • CAR-T cell therapy research
  • Immune cells in cancer
  • Extracellular vesicles in disease
  • Glioma Diagnosis and Treatment
  • Pluripotent Stem Cells Research

Naldini has been recognized as a member of the European Molecular Biology Organization (EMBO).

Best Publications

  • In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

    Luigi Naldini;Ulrike Blömer;Philippe Gallay;Daniel Ory

  • A Third-Generation Lentivirus Vector with a Conditional Packaging System

    Tom Dull;Romain Zufferey;Michael Kelly;R. J. Mandel

  • Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.

    Romain Zufferey;Dea Nagy;Ron J. Mandel;Luigi Naldini

  • Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery

    Romain Zufferey;Thomas Dull;Ronald J. Mandel;Anatoly Bukovsky

  • Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

    Luigi Naldini;Ulrike Blomer;Fred H. Gage;Didier Trono

  • Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

    Mark A. Kay;Joseph C Glorioso;Luigi Naldini

  • Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

    F Bussolino;M F Di Renzo;M Ziche;E Bocchietto

  • Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

    Michele De Palma;Mary Anna Venneri;Rossella Galli;Lucia Sergi Sergi

  • Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences.

    Antonia Follenzi;Laurie E. Ailles;Silvia Bakovic;Massimo Geuna

  • Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.

    Alessandra Biffi;Eugenio Montini;Laura Lorioli;Martina Cesani

  • Gene therapy returns to centre stage

    Luigi Naldini

  • Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome

    Alessandro Aiuti;Luca Biasco;Samantha Scaramuzza;Francesca Ferrua

  • Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery

    A. Lombardo;A. Lombardo;P. Genovese;P. Genovese;C.M. Beausejour;C.M. Beausejour;S. Colleoni;S. Colleoni

  • Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector.

    Ulrike Blömer;Luigi Naldini;Tal Kafri;Didier Trono

  • Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET.

    L Naldini;E Vigna;R P Narsimhan;G Gaudino

  • Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

    Eugenio Montini;Daniela Cesana;Manfred Schmidt;Francesca Sanvito

  • Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.

    L. Naldini;K.M. Weidner;E. Vigna;G. Gaudino

  • Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor.

    Luigi Naldini;Luca Tamagnone;Elisa Vigna;Martin Sachs

  • Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells

    Roberta Mazzieri;Ferdinando Pucci;Davide Moi;Erika Zonari

  • Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells.

    Michele De Palma;Mary Anna Venneri;Cristina Roca;Luigi Naldini

Frequent Co-Authors

Maria Grazia Roncarolo
Maria Grazia Roncarolo Stanford University
Alessandro Aiuti
Alessandro Aiuti Vita-Salute San Raffaele University
Eugenio Montini
Eugenio Montini IRCCS Ospedale San Raffaele
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University
Paolo M. Comoglio
Paolo M. Comoglio FIRC Institute of Molecular Oncology
Michael C. Holmes
Michael C. Holmes Ambys Medicines
Claudio Bordignon
Claudio Bordignon MolMed (Italy)
Antonia Follenzi
Antonia Follenzi University of Eastern Piedmont Amadeo Avogadro
Michele De Palma
Michele De Palma École Polytechnique Fédérale de Lausanne
Philip D. Gregory
Philip D. Gregory Sangamo BioSciences (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Molecular Biology opens doors to a diverse range of educational and career opportunities—many of which are available online. For students interested in exploring how life sciences intersect with society, human services online degree programs offer a pathway to roles in community outreach, healthcare coordination, and advocacy.

A background in biology can also support those looking to make a career change. For example, educated professionals might consider transitioning from teacher to speech language pathologist. Learn more about this pathway through the guide on teacher to speech language pathologist.

Those interested in combining scientific principles with design and engineering may find naab-accredited online architecture degrees a unique blend of creativity and technical expertise—relevant for careers in laboratory design or bio-inspired architecture.

Analytical skills are crucial in Molecular Biology, making quantitative programs appealing. If you have a strong affinity for numbers, consider pursuing a math degree online to expand your opportunities into data analysis, bioinformatics, or educational roles in STEM.

Best Scientists Citing Luigi Naldini

Trending Scientists

Recently Published Articles